drugset / Trial / NCT04414605
Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to determine whether oral Chinese herbal medicine in combination secukinumab is effective and safe in the treatment of severe psoriasis.
Timeline
- Start
- 2020-06-04
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gu Ben Hua Yu Fang | Traditional medicine (herbal / TCM) | — | Oral |
| Subject | Secukinumab | Monoclonal antibody | 300 mg | Subcutaneous |